StemCell Therapy

A rising Gainesville High School junior will volunteer at a Dominican Republic camp for children with Type 1 diabetes.

Cassidy ONeill has spent most of her life with Type 1 diabetes. Diagnosed at 16 months, the rising Gainesville High School junior is about to take her first trip out of the country to help other children with the disease.

ONeill, 16, will travel to Santo Domingo, the capital of Dominican Republic, to help run Campo Amigo Dominicano, a camp designed for children with Type 1 diabetes to learn how to follow a healthy lifestyle.

Type 1 diabetes occurs when ones pancreas produces too little insulin and the immune system attacks the pancreas insulin-producing cells.

As a kid, its scary, ONeill said. Shes used an insulin pump most of her life, and every 5 minutes her glucose monitor tests her blood sugar. She and her parents can check the results on their phones.

Some people arent as fortunate as Ive been, ONeill said.

In the Dominican Republic, people need blood test strips, syringes and insulin, she said. Accessible education is lacking, too.

Its really hard to find resources and support, she said.

The goal of the camp, which begins Saturday, is to educate children and empower them to live full lives in spite of their illness. Camp volunteers are asked to raise funds, and ONeill has already met the $6,500 target, selling wristbands to her fellow students and exploring other resources.

Because the camp is in the capital, children from across the country come. Its four days long, but ONeill will head out early to help plan and organize the camp. It will be her first time out of the country, although shes advocated for Type 1 diabetes awareness across the United States.

Its a big part of my life, she said.

Originally posted here:
Teen makes diabetes impact abroad - Gainesville Sun

Type 2 Diabetes is a serious condition for anyone, but area Latinos, men, and youth sometimes face extra barriers to early diagnosis and management.

People with Type 2 Diabetes make insulin, but not enough or their bodies become resistant to it. If not diagnosed early or properly managed, the condition can lead to irreversible damage to major body organs such as the kidneys, eyes, blood vessels and nerves.

Latinos, African Americans, Native Americans and Asian Americans are ethnically predisposed to higher rates of Type 2 Diabetes, said Amy Knights, registered nurse, Northwest Colorado Health Diabetes educator and community health manager.

In the past, language was a barrier for Spanish speaking Latinos, Knights said.

Last year Northwest Colorado Health started a number of programs, providing on-sight interpretation and education about prevention and management by people who speak the language.

Early diagnosis and management is important to preventing disease progression and avoiding irreversible damage.

"Men are usually less likely to seek preventative care. Men tend to wait until things are really bad. The biggest barrier in this group of patients is their own attitudes towards prevention," Knights said.

The American Diabetes Association reminds men that it's important to talk about their health with doctors and to seek early intervention to avoid complications that can include erectile dysfunction.

Type 2 diabetes isn't an adults only health problem.

"More and more kids are being diagnosed with it, some as young as 10 years old," according the Centers for Disease Control and Prevention update Thursday.

The increase is due to inactivity leading to weight gain.

"Weight is still the biggest precursor to diabetes," Knights said when explaining that she's seeing more local children tested.

She believes that management is extra challenging when youth are diagnosed with the disease because it often means life style changes for the entire family.

"If you have diabetes and you are trying to make those changes, it won't happen overnight," Knights said. "So give yourself enough time to make those life style changes so that you can succeed."

Contact Sasha Nelson at 970-875-1794 or snelson@CraigDailyPress.com or follow her on Twitter @CDP_Education

Link:
Latinos, men, youth face challenges in diabetes diagnosis, management - Craig Daily Press

News & Observer

'Smart' insulin patches developed at UNC, NCSU one step closer to market News & Observer Zhen Gu, whose team at the UNC-N.C. State Biomedical Engineering Program has been leading the effort to develop smart insulin patches for treating diabetes, co-founded a company based in Research Triangle Park two years ago with the idea of ... and more »

View post:
'Smart' insulin patches developed at UNC, NCSU one step closer to market - News & Observer

FRIDAY, June 30, 2017 (HealthDay News) -- Almost half of people with type 1 diabetes are still producing some insulin more than a decade after being diagnosed with the disease.

The new findings challenge previous assumptions that people with type 1 diabetes lose the ability to produce any insulin -- a hormone that helps usher sugar to cells to be used as fuel -- over time.

Researchers at Sweden's Uppsala University, led by post-doctoral researcher Daniel Espes, reached their conclusions after studying more than 100 patients with type 1 diabetes.

The investigators found that people who still produced insulin despite their long-standing type 1 diabetes had higher levels of a protein called interleukin-35. This protein appears to play an important role in the immune system.

Past research had shown that both newly diagnosed people with type 1 diabetes and those who've had the disease for some time had lower average levels of interleukin-35 compared to healthy people.

Type 1 diabetes is an autoimmune disease that causes the body's immune system to mistakenly attack healthy cells in the pancreas that make insulin.

This leaves people without enough insulin to meet the body's daily needs. To survive, people with type 1 diabetes must replace that lost insulin through multiple daily injections or through a tiny tube inserted under the skin every few days and then attached to an insulin pump.

The Uppsala researchers have launched a new study to see if they may be able to boost insulin production in those people with type 1 diabetes who are still making insulin.

The study appears in the June issue of Diabetes Care.

For more about type 1 diabetes, visit JDRF.

Read more:
Many People With Type 1 Diabetes Still Make Some Insulin - Sioux City Journal

In the summer of 2012, Sami Inkinen was 36, wealthy, and semiretired. Trulia, the online real estate company he cofounded and nurtured from a startup to a business with some 20 million users, had filed to go public, and he had decided to cease his operational role. The eight-year journey had been rewarding but exhausting. Inkinen planned to focus on angel investing.

That would leave plenty of time for his main hobby: triathlons. A champion who obsessively tracks his biometrics, Inkinen was a fitness freak even by Silicon Valley standards. He had less than 8% body fat.

But life is full of ironic twists, and he was hurtling toward a particularly sharp one. Soon after Trulia went public, Inkinen noticed something strange: His blood sugar levels were above normal and rising. He was prediabetic.

Inkinen skipped the doctor and began researching on his own. After discovering a decades-old paper that showed Type 2 diabetes can be prevented and sometimes reversed through lifestyle changes alone, he switched to a low-carbohydrate, high-fat diet. As his blood sugar levels dropped, his excitement spiked.

This spring he took his mission even further: Inkinen launched Virta Health , a 60-person startup backed by $37 million in funding. The service combines Inkinens passiona data-heavy appwith the same medical approach that he credits with reversing his prediabetes. Virta is one of a handful of companies attempting to attack the epidemicsome 28 million Americans suffer from Type 2 diabeteswithout relying on medications.

Researchers long believed Type 2 diabetes was not curable, but today the prevailing view is that it can be reversed by weight loss, says Dr. George King, the chief scientific officer at Joslin Diabetes Center and a professor at Harvard Medical School.

More: A New Innovation for Type 2 Diabetes

In that sense, Inkinen is an improbable advocate. He seemed like an unlikely candidate to be heading toward Type 2 diabetes in the first place. A native of Finland, Inkinen was always very active, but his seemingly healthy diet was packed with sugar (in the form of fruit smoothies) and carbs (five bowls of oatmeal a day). After diagnosing himself as prediabetic, he abruptly cut back on carbs and sugar. (Today hes an evangelist for a ketogenic diet, the food trend of the moment in Silicon Valley. It embraces high-fat foods and limits carbs to less than 50 grams a day, the equivalent of a cup of brown rice.)

Inkinen credits that diet for fueling an epic journey: He and his wife rowed from Monterey, Calif., to Hawaii to raise awareness of the dangers of sugar. During the 45 days it took to paddle across 2,700 miles of the Pacific, Zillow ( z ) agreed to acquire Trulia for $2.5 billion. Still a board member, Inkinen approved the sale via satellite phone.

Having sold the company and completed his physical quest, Inkinen was ready for a new mission. Im not a spiritual person, he says, but I knew I had to make this happen. After he met Dr. Stephen Phinney, the author of the paper that had convinced him that diet could solve his condition, a solution began to take shape in Inkinens mind.

Today Virtas service begins with an in-depth video session with a company doctor, who goes over each patients medical history and lifestyle to develop an eating strategy. Virta mails customers devices to record blood sugar, ketones (which indicate low insulin), and blood pressure. Patients enter data into the app, and a wireless scale automatically sends their weight to Virta. Each patient is then assigned a health coach, who monitors the data.

Users text their coaches daily via the app (some people prefer to call or use video chats). Advice gets granular. If a patient is planning to attend a birthday party, for example, her health coach could help develop an eating strategy beforehand.

Many patients are on medications when they begin the Virta program, and the goal is to slowly transition them off. Both meal recommendations and medications are constantly adjusted depending on what is, and isnt, having a positive effect on blood sugar, says Dr. Sarah Hallberg, the companys medical director.

Virta subscribes to a low-carb diet with moderate protein and fat, but its not doctrinaire. We accept any lifestyle and diet, says Inkinen. Instead of telling a person to swear off fast food, an often unrealistic option, health coaches recommend low-carb options on the menu. Physical activity is encouraged but not mandatory. You want someone to exercise when they come to you and say theyre ready, says Hallberg.

More: This Health Startup Plans to Challenge the Multibillion-Dollar Diet Industry

The service doesnt come cheap: It costs $400 a month (and isnt covered by insurance, though some employers health plans will reimburse for it). Virta has several thousand patients, according to Hallberg, served by about 20 health professionals.

The goal is to create a plan dramatic enough that it lowers blood sugar, but not so extreme that its unsustainable. In a clinical trial conducted in partnership with Indiana University Health, researchers found that 56% of the roughly 240 participants on the Virta platform lowered their blood sugar below diabetic levels by the end of the 10-week trial, and 87% no longer needed insulin.

Whether these results can be maintained is another question. The first couple of months of a diet are easy compared with an indefinite, fry-less future. Hallberg contends that the personalized support paired with the benefits of reduced medication and weight loss will keep people motivated despite the copious research establishing how hard most people find it to change their patterns.

Inkinen understands that as an endurance athlete he has more discipline (and capacity for suffering) than most people. His goal with Virta, as it was with Trulia, is to turn what was once a personal problem into a service that a large number of people can use. The stakes are higher this time around.

A version of this article appears in the July 1, 2017 issue of Fortune.

Original post:
Fighting Diabetes With Food - Fortune

AMARILLO - Medication or healthy food?

It's a decision many in our area have to choose between when spending their money.

But for 12 weeks, more than a dozen people suffering from type two diabetes had the chance to solely focus on their health.

Norma Mata isn't the same woman she was after starting on a 12-week lifestyle change.

"My food intake has been better," said Mata. "More salads, more grilled meats, and things of that sort."

Despite living with type two diabetes, she decided to take control of her health.

"My sugars have gone down tremendously. Eating healthy is beneficial for our health," added Mata.

High Plains Food Bank officials say they recognized the need to provide foods that heal, so they initiated a partnership with Heal the City.

The group noted that many of their patients are living with type two diabetes and could benefit from nutrition-based interventions.

"Most of these patients had been diabetic for over ten years," said Rachel Scott, a Clinic Coordinator for Heal the City. "A lot of them said no, I don't really know what it means, I don't really know what I'm supposed to eat."

This led both non-profits to create a 12-week pilot program called "Food to Health".

We're told it includes nutrition education, healthy food, and medical care for food insecure patients who struggle with type two diabetes.

"The good thing about this program is not only do they help your health get better and have all these bad numbers go down., they taught you how to do that so you can take that knowledge home," said Lourdes Sanchez, another participant of "Food to Health". "You know that when you go shopping you have to look at the nutritional facts, you know what to look for, so you're able to continue forward with what happened during the program because they taught you how to do it yourself. "

Mata and Sanchez are part of the twenty participants who started on this 12-week "Food to Health" journey.

Next week Scott says 16 of them will graduate from the program.

Before the program started, "Food to Health" participants had tests and blood work done. Next week, they will get their lab results to compare their progress.

Mata and Sanchez tell us after changing their diet and mindset, they noticed a big difference.

Officials say individuals and families who lack consistent access to enough healthy food may have a higher risk of developing chronic diseases like obesity, hypertension and type two diabetes.

Read more from the original source:
Local Organizations Helping to Fight Type Two Diabetes - MyHighPlains

ALTON Alton Memorial Hospitals Diabetes Management office has earned the prestigious American Diabetes Association Education Recognition Certificate. The ADA believes that this program offers high-quality education that is an essential component of effective diabetes treatment.

The Associations Education Recognition Certificate assures that educational programs meet the national standards for diabetes self-management education programs.

The process gives professionals a national standard by which to measure the quality of services we provide, said Lisa James, diabetes educator at AMH. And, of course, it assures the consumer that he or she will receive high-quality service.

Education Recognition status is verified by an official certificate from ADA and awarded for four years.

Self-management education is an essential component of diabetes treatment. One consequence of compliance with the national standards is the greater consistency in the quality and quantity of education offered to people with diabetes. The participant in a recognized program will be taught, as needed, self-care skills that will promote better management of his or her diabetes treatment regimen. All approved education programs cover the following topics as needed: diabetes disease process; nutritional management; physical activity; medications;

monitoring; preventing, detecting, and treating acute complications; preventing, detecting, and treating chronic complications through risk reduction; goal setting and problem solving; psychological adjustment; and preconception care, management during pregnancy, and gestational management.

Unnecessary hospital admissions and some of the acute and chronic complications of diabetes may be prevented through self-management education.

According to the American Diabetes Association, there are 29.1 million people or 9.3 percent of the population in the United States who have diabetes. While an estimated 21 million people have been diagnosed, 8.1 million people are not aware that they have this disease. Each day more than 3,900 people are diagnosed with diabetes. Many will first learn that they have diabetes when they are treated for one of its life-threatening complications heart disease and stroke, kidney disease, blindness, and nerve disease and amputation.

For more information about diabetes education at Alton Memorial, call Lisa James at 618-463-7526.

James

http://thetelegraph.com/wp-content/uploads/2017/06/web1_Lisa-James.jpgJames

.

Here is the original post:
Alton Memorial Hospital's diabetes program honored by ADA - Alton Telegraph

Podimetrics, a startup created during an MIT hackathon in 2011, focuses on catching foot ulcersa complication of diabetes that can lead to amputationearly. The company unveiled data showing its remote-monitoring technology caught a majority of foot ulcers well before they appeared.

A number of factors contribute to the development of diabetic foot ulcers, including nerve damage, which stops patients from feeling small injuries in their foot. A healthy person might change his or her movement or adjust a shoe, but a person with diabetes-related nerve damage will not notice the pain. Repetitive injury over time can lead to an ulcer, and early detection can help prevent an ulcer from forming or getting worse.

American Diabetes Association guidelines recommend that people with diabetes undergo a comprehensive foot evaluation each year. Patients with a history of ulcers or amputations, insensate feet, foot deformities or peripheral artery diseaseshould get their feet checked out at every doctors visit.

The Podimetrics Remote Temperature Monitoring System is designed for the ongoing assessment of patients' feet. Itrelies on the concept that tissue heats up before it becomes a wound, said CEO Jonathan Bloom, M.D. A patient steps on the system's Smartmatfor 20 seconds at a time and it measures the temperature difference at various locations on the feet. Specifically, the software is looking for a hotspot, or a place where the temperature is persistently higher than in other areas.

A monitoring service alerts patients and physicians when the data show that inflammation may develop. The patient and physician then work together to prevent an ulcer from forming.

In a real-world setting, when a doctor gets a notification that a patient has a hotspot, the patient will be advised to reduce physical activity for a period to let the developing wound heal or may be asked to come in for a visit in serious cases, said lead investigator Robert Frykberg, M.D., of the Carl T. Hayden Veterans Affairs Medical Centerin a statement.

The 129-patient study, published in Diabetes Care, showed that the SmartMat detected as many as 97% of developing nontraumatic plantar foot ulcers an average of five weeks before they presented clinically. Additionally, 86% of patients used the device at least three times a week, and 88% of them said it was easy to use.

This is the big part, Bloom said. People actually use it.

[This] is critical for adherence and ultimately achieving ongoing prevention of [diabetic foot ulcers] and its devastating complications, he said in the statement.

See more here:
Study: Temperature-reading 'smartmat' catches diabetic foot ulcers early - FierceBiotech

Lifestyle is a decisive factor in preventing or stabilising diabetes. From diet and exercise to stress management, here are a few lifestyle changes to consider.

Diabetics dont need to have to skip dessert, but they should definitely make wise food choices.

Pick products that have a naturally low glycemic index to prevent spikes in blood sugar.

Top fruits on that front are red berries (raspberries, strawberries, blackberries, blueberries), apples, pears, oranges, grapefruit, peaches and nectarines.

Note that cinnamon can help lower blood sugar levels.

It can be used to sweeten coffee or tea or sprinkled on yogurt or fromage frais.

Certain bakeries make cakes and cookies specifically for diabetics.

These sweet treats typically contain half the amount of sugar, notably by using natural sugar substitutes.

Still, they should only be eaten occasionally and always as part of a meal in order to limit the hyperglycemic effect.

Add berries and fruit to your deserts.

Most diabetics know that they should avoid pre-prepared supermarket dishes and ready meals.

These meals are often too high in fat and salt, and can be lacking in vitamins and minerals.

Cooking from scratch with quality produce remains the best option.

When it comes to grains, oats and barley are allowed.

These cereals fibres slow down the absorption of carbohydrates in the intestine and help control blood sugar levels and insulin requirements.

Walking for 10 minutes right after eating could be more effective for controlling blood sugar than walking at another time of day.

Do this after an evening meal, when blood sugar can drop by 22%, according to research from New Zealand.

Current recommendations from the World Health Organization (WHO) recommend at least the equivalent of 30 minutes of moderate-intensity physical activity per day, five times a week.

You can develop diabetes from too much stress and not enough sleep.

Unfortunately, it is possible to develop type-2 diabetes due to chronic stress from work or personal lives.

Permanent stress can contribute to increasing insulin resistance.

Thats why it is recommended to take regular exercise, learn relaxation techniques and organize break times on downtime in your day.

Keep an eye on shut-eye too (minimum seven hours sleep per night), as, according to several studies, this can help curb cravings for fatty or sugary foods, among other things. AFP Relaxnews

All comments are moderated. Your comment may not show up immediately. Please keep it clean and on topic. Offensive comments will not be published.

Visit link:
If you really want to take control of your diabetes, follow these 4 tips - Star2.com

Cynthia McCormick @Cmccormickcct

WEST BARNSTABLE The YMCA Cape Cod is holding a grand opening of its newly renovated Weny Diabetes Resource Center at 5 p.m. today with an emphasis on nutrition counseling and classes for Cape Codders with diabetes and prediabetes.

Were trying to make this free and open to the public, said YMCA of Cape Cod CEO and President Stacie Peugh.

Individuals diagnosed with type 1 or 2 diabetes are entitled to five free visits with nutritionist Lauren Kunkler, Peugh said.

As part of its diabetes programming, the YMCA of Cape Cod also hosts prediabetes education and lifestyle coaching classes at the Mashpee-based Community Health Center of Cape Cod, Harbor Health Services in Hyannis, Duffy Health Center in Hyannis and the Falmouth Service Center, Peugh said.

The YMCA is planning to launch a support group for people with diabetes in collaboration with NAMI Cape Cod & the Islands, an advocacy group for people with mental illness, Peugh said.

There is actually a correlation between depression and diabetes, Peugh said during an interview in the newly renovated resource center, located by the front door of the YMCA.

With its blond wood shelving, soft blue-green walls and clear plastic furniture, the resource center is fairly small in size but was designed to appear bright and inviting, said Paula Drury of Brown, Lindquist Fenuccio & Raber Architects, the architect/designer for the project.

Located since 2008 at the back of the YMCA building where the front door used to be situated the new position is designed to attract the attention of the hundreds of people who enter the Y each day, Peugh said.

In addition to individual consulting, the diabetes center was designed to serve as a library and resource center for people with diabetes and their families, Drury said.

Websites relating to diabetes and health care have been built into two Apple desktop stations, and books and informational packets fill the resource centers book shelves.

The space and services offered are designed to help guide people past nutrition information overload and into useful, health-enhancing practices, Peugh said.

Diabetes is considered a metabolism disorder that affects the way the body uses food, according to information online from Cape Cod Healthcare.

The pancreas of diabetics either produces too little insulin, or the cells of the body do not respond to the insulin that is produced, according to the fact sheet.

The resulting glucose accumulation in the body can lead to multiple health issues including heart disease, kidney disease, stroke, nerve damage and blindness.

According to a public information platform called DataUSA, 8.6 percent of Barnstable County residents are living with diabetes. The percentage was based on data collected in 2013.

Todays open house will feature an appearance by Roger Ludwig, a trustee with the Weny Charitable Trust, and a discussion of the centers new partnership with NAMI, Peugh said.

Refreshments will be served. Peugh said the Weny Charitable Trust,which contributed $1 million to the expansion of the YMCA of Cape Cod 10 years ago, funded the relocation and renovation of the diabetes resource center with a gift of $100,000.

Follow Cynthia McCormick on Twitter: @CmccormickCCT.

See the original post here:
Expanded diabetes center opens today - Cape Cod Times (subscription)

Diabetes can be deadly. Each year, more than 70,000 Americans die from complications of the disease. About half of all people with type 2 diabetes dont have their condition under control. Now, new research shows a well-known procedure for weight loss may be the best bet for patients with uncontrolled diabetes.

This was the old Lisa Shaffer. At her heaviest: almost 300 pounds!

When I was obese, my life was so limited, Lisa said.

Her health suffered, too. Lisa had type 2 diabetes, and she tried everything to control it.

She explained, Nothing worked, nope.

But today, Lisa is 120 pounds lighter and her diabetes is gone. The reason; gastric bypass surgery.

Its been incredible. Yeah. It really did give me my life back. she exclaimed.

Phillip Schauer, MD, Director of the Cleveland Clinic Bariatric and Metabolic Institute in Cleveland, Ohio, led a study that compared bariatric surgery, either gastric bypass or gastric sleeve, to intense medical therapy in people with diabetes. After five years, the gastric bypass patients did the best. Many were in complete remission without drugs or insulin.

Which is pretty remarkable. Thats about as close to a cure that you can get, Dr. Schauer explained.

Twenty-nine percent of gastric bypass and 23 percent of gastric sleeve patients achieved and maintained normal blood sugar levels -compared to just 5 percent of medication-only patients. The surgery groups also lost more weight and reported a better quality of life.

The patients who had surgery did better and were happier at the five- year mark, Dr. Schauer stated.

Three days after her surgery, Lisa was off all of her meds. Her A1c, a measure of blood sugar control, was 10.5 before the surgery and today, its 5.3. Now shes able to live the life shes always wanted.

Ever since I lost the weight, Ive run three 5ks. Ive done zip lining with the family, which is fantastic. Just no limits anymore, theres no limitations on my life anymore. she said.

Doctor Schauer says weight loss is one reason diabetes patients benefit from bariatric surgery. The other is something that happens in the body as a result of the surgery. When the intestines are bypassed, special hormones increase, which helps the pancreas produce insulin more effectively.

See the original post here:
Best bet for uncontrolled diabetes - WTAJ

Please take note this is only one aspect in weighing the attractiveness or non-attractiveness of the companies mentioned as an investment and should not be used independent of other factors. This article examines one segment of the companies' businesses, and other factors such as valuation are not addressed.

Chinas dialysis population has seen a steady increase over the years.

Source: Wolfgang Meichelboeck, Dipl.-Ing. Pentenried Germany

The number of dialysis cases is growing in China. China had approximately 440,000 dialysis patients last year, an increase of 80% over five years.

Source: European Renal Association

The national prevalence of chronic kidney disease (CKD) was 10.8% (estimated at over 100 million Chinese) and end stage renal disease (ESRD) stood at 0.03% of the Chinese population.

Diabetes is the leading cause of end-stage kidney disease worldwide, although glomerular disease tended to be the leading cause in China caused for instance by taking medications and herbal medicines which damage the kidneys.

Source: nature.com

However, after decades of economic growth and the resulting unhealthy change in dietary habits, diabetes cases have seen a corresponding increase in China and this has contributed to a shift in the causes of kidney failure in China. A study found that chronic kidney disease related to diabetes was progressively becoming more common than chronic kidney disease related to glomerulonephritis in both the general population and hospitalized urban population in China. In 2010, among hospitalized patients, the percentage with chronic kidney disease related to diabetes was lower than the percentage with chronic kidney disease related to glomerulonephritis (0.82% vs. 1.01%). Beginning in 2011, the percentage with chronic kidney disease related to diabetes exceeded the percentage with chronic kidney disease related to glomerulonephritis, and the gap between them increased progressively.

Source: The New England Journal of Medicine

In 2015, the percentage of the hospitalized Chinese population with chronic kidney disease related to diabetes and to glomerulonephritis was 1.10% and 0.75%, respectively. In both 2010 and 2015, the percentage of hospitalized urban patients with chronic kidney disease related to diabetes was higher than that of hospitalized urban patients with chronic kidney disease related to glomerulonephritis, and the gap had increased by 2015 (1.02% vs. 0.84% in 2010 and 1.55% vs. 0.72% in 2015). However, among hospitalized rural patients during that same time frame, glomerulonephritis-related chronic kidney disease predominated, and the percentage with chronic kidney disease related to diabetes was lower than the percentage with chronic kidney disease related to glomerulonephritis, though the gap had narrowed by 2015 (0.68% vs. 1.51% in 2010, and 0.76% vs. 0.95% in 2015).

Chinas economic growth led to changes in Chinese citizens lifestyle and dietary habits. In the 1980s diabetes affected just about 1% of Chinas population. By 2015, this figure rose to roughly 10% of Chinas population, numbering around 110 million (compared to the U.S. where it is about 30 million) making it the country with the highest number of diabetics in the world and home to about a third of the worlds diabetic population.

The number is expected to continue rising as diets change in the country alongside economic growth. Almost 500 million people in China are estimated to be pre-diabetic about 1 times the size of the entire U.S. population.

By 2040, China is expected to have 150 million diabetics, presenting a growth opportunity for companies such as Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY) and Sanofi (NYSE:SNY) which are the leading multinational insulin providers in China accounting for over 80% of Chinas insulin market.

Source: Marketwatch

The rate of chronic kidney disease increases with age, reaching over 30% of adults aged 70 years and older according to a study conducted by Peking University first Hospital.

The increasing incidence of obesity (over one third of adults in China are overweight and 7% of adults are obese) and Type II diabetes (a major risk factor for kidney disease), along with an aging population (in 2015, 9.5% of Chinas population was aged 65 or older and the U.N. projects this percentage to increase to 27.5% by 2050) suggests China could see rising chronic kidney disease (CKD) cases going forward.

Access to dialysis is lower in developing countries than developed countries, for reasons such as financial constraints and inadequate clinical infrastructure.

Source: The George Institute

China, the worlds largest developing country bears an enormous burden of kidney disease. For reasons such as a lack of financial and clinical resources, the rate of patients currently receiving dialysis treatment in China is lower than in developed countries such as the United States.

Majority of Chinese renal failure patients, mostly located in rural China do not have access to dialysis. While dialysis treatment is available for patients in urban China, access to dialysis treatments is inadequate for patients in the rest of the country due to a shortage of equipment, doctors and limited awareness levels.

Of the approximately 100 million Chinese with chronic kidney disease, about 2% of these patients are expected to develop into end stage kidney disease which means approximately 2 million people will require renal treatment therapy. However, according to the national renal registries, the number of patients who actually received treatment was less than 0.5 million.

According to a report by the American Journal of Kidney Diseases, in China, less than 30% of patients with end-stage kidney disease are treated with dialysis. For the rest, renal treatment therapy is not available due to a number of factors such as financial constraints, inadequate infrastructure and limited awareness.

Chinas ongoing healthcare reform is expected to alleviate this shortage of dialysis supply. Basic medical insurance covers over 90% of Chinas population and a high reimbursement policy for catastrophic diseases including end stage kidney disease has been established.

A report by Allied Market Research expects the global dialysis market to expand at a CAGR of 4.5% between 2017 and 2023 and Asia-Pacific led by China is expected to witness the highest growth rate during the forecast period presenting an opportunity for dialysis companies.

Chinas dialysis market is still at early stages and offers long term growth potential. Chinas dialysis market is dominated by foreign brands with over 90% of dialysis equipment and over 80% of hemodialysis consumables in China being imported from overseas.

Fresenius Medical Care (NYSE:FMS) and DaVita (NYSE:DVA) two of the worlds largest dialysis product companies are well established in the Chinese dialysis market. A few years ago, Fresenius opened an R&D center in Shanghai and this year, Fresenius acquired a 70% stake in Kunming Wuhua Health Hospital, a private Grade II hospital in Kunming (the capital of Yunnan province) which is specialized in chronic disease management and hemodialysis. This marks the companys first joint venture (JV) hospital in China and may be aimed at capitalizing on a new policy issued by the China State Council and The National Health And Family Planning Council which states that chronic disease management will be gradually migrated from larger hospital outpatient departments to smaller Grade II hospitals and community hospitals.

DaVita entered into a joint venture with Shunjing Renal Hospital in China with the aim of building and operating dialysis chains.

Early this year Baxter (NYSE:BAX) announced that it was exiting India, Turkey and Venezuela this year and refocusing its business on Latin America and China. China is expected to become a US$ 1 billion market in the next few years. Baxter operates a Flying Angel program in partnership with China's Ministry of Health, which is aimed at improving access to peritoneal dialysis for patients in rural areas.

Most renal treatment therapy (RRT) in China occurs at HD (hemodialysis) centers and the country has about 4,000 dialysis centers.

Source: Wolfgang Meichelboeck, Dipl.-Ing. Pentenried Germany

Hemodialysis is costlier than peritoneal dialysis not only for the patients but also for Chinas healthcare system as well. With the prevalence of end stage renal disease in China increasing rapidly, the government has begun examining the feasibility of expanding peritoneal dialysis as a treatment option in China.

A report assessing dialysis options and costs in China from the National Health Development Research Center showed that the annual cost of peritoneal dialysis (PD) is about 93,520 Chinese yuan (US $14,380), whereas the cost of in-center hemodialysis (HD) is 103,416 Chinese yuan (US $15,910). The report also notes the advantages of PD for patients in rural areas. Peritoneal dialysis is a home-based treatment, offering greater freedom for rural patients and reducing the inconvenience and financial burden of having to commute several times a week to and from the hospital for treatment. To facilitate peritoneal dialysis expansion, the Chinese government is planning on adjusting reimbursement policies and the Chinese Ministry of Health has certified over 30 training centers across the country to promote the implementation of peritoneal dialysis by establishing regional satellite centers which would provide staff training, patient education and the implementation of quality assurance protocols. Baxter appears well positioned to capitalize on this opportunity. Morningstar estimates that Baxter absolutely dominates the global peritoneal dialysis market with a 72% market share.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Excerpt from:
China's Dialysis Market: Potential For Growth Driven By Diabetes And Aging Population - Seeking Alpha

June 23, 2017 Researchers at the University of Texas at Dallas have developed a wearable diagnostic biosensor that can detect three interconnected, diabetes-related compounds -- cortisol, glucose and interleukin-6 -- in perspired sweat for up to a week without loss of signal integrity. The team envisions that their wearable devices will contain a small transceiver to send data to an application installed on a cellphone. Credit: University of Texas at Dallas

Researchers at The University of Texas at Dallas are getting more out of the sweat they've put into their work on a wearable diagnostic tool that measures three diabetes-related compounds in microscopic amounts of perspiration.

"Type 2 diabetes affects so many people. If you have to manage and regulate this chronic problem, these markers are the levers that will help you do that," said Dr. Shalini Prasad, professor of bioengineering in the Erik Jonsson School of Engineering and Computer Science. "We believe we've created the first diagnostic wearable that can monitor these compounds for up to a week, which goes beyond the type of single use monitors that are on the market today."

In a study published recently in Scientific Reports, Prasad and lead author Dr. Rujute Munje, a recent bioengineering PhD graduate, describe their wearable diagnostic biosensor that can detect three interconnected compounds - cortisol, glucose and interleukin-6 - in perspired sweat for up to a week without loss of signal integrity.

"If a person has chronic stress, their cortisol levels increase, and their resulting insulin resistance will gradually drive their glucose levels out of the normal range," said Prasad, Cecil H. and Ida Green Professor in Systems Biology Science. "At that point, one could become pre-diabetic, which can progress to type 2 diabetes, and so on. If that happens, your body is under a state of inflammation, and this inflammatory marker, interleukin-6, will indicate that your organs are starting to be affected."

Last October, Prasad and her research team confirmed they could measure glucose and cortisol in sweat. Several significant advances since then have allowed them to create a more practical, versatile tool.

"We wanted to make a product more useful than something disposable after a single use," Prasad said. "It also has to require only your ambient sweat, not a huge amount. And it's not enough to detect just one thing. Measuring multiple molecules in a combinatorial manner and tracking them over time allows us to tell a story about your health."

One factor that facilitated their device's progress was the use of room temperature ionic liquid (RTIL), a gel that serves to stabilize the microenvironment at the skin-cell surface so that a week's worth of hourly readings can be taken without the performance degrading over time.

"This greatly influences the cost model for the deviceyou're buying four monitors per month instead of 30; you're looking at a year's supply of only about 50," Prasad said. "The RTIL also allows the detector to interface well with different skin typesthe texture and quality of pediatric skin versus geriatric skin have created difficulties in prior models. The RTIL's ionic characteristics make it somewhat like applying moisturizer to skin."

Prasad's team also determined that their biomarker measurements are reliable with a tiny amount of sweatjust 1 to 3 microliters, much less than the 25 to 50 previously believed necessary.

"We actually spent three years producing that evidence," Prasad said. "At those low volumes, the biomolecules expressed are meaningful. We can do these three measurements in a continuous manner with that little sweat."

Prasad envisions that her wearable devices will contain a small transceiver to send data to an application installed on a cellphone.

"With the app we're creating, you'll simply push a button to request information from the device," Prasad said. "If you measure levels every hour on the hour for a full week, that provides 168 hours' worth of data on your health as it changes."

That frequency of measurement could produce an unprecedented picture of how the body responds to dietary decisions, lifestyle activities and treatment.

"People can take more control and improve their own self-care," Prasad said. "A user could learn which unhealthy decisions are more forgiven by their body than others."

Prasad has emphasized "frugal innovation" throughout the development process, making sure the end product is accessible for as many people as possible.

"We've designed this product so that it can be manufactured using standard coating techniques. We made sure we used processes that will allow for mass production without adding cost," Prasad said. "Our cost of manufacturing will be comparable to what it currently takes to make single-use glucose test stripsas little as 10 to 15 cents. It needs to reach people beyond America and Europeand even within first-world nations, we see the link between diabetes and wealth. It can't simply be a small percentage of people who can afford this."

Prasad was motivated to address this specific problem in part by her own story.

"South Asians, like myself, are typically prone to diabetes and to cardiovascular disease," Prasad said. "If I can monitor on a day-to-day basis how my body is responding to intake, and as I age, if I can adjust my lifestyle to keep those readings where they need to be, then I can delay getting a disease, if not prevent it entirely."

For Prasad, the latest work is a fulfilling leap forward in what has already been a five-year process.

"We've been solving this problem since 2012, in three phases," Prasad said. "The initial concept for a system level integration of these sensors was done in collaboration with EnLiSense LLC, a startup focused on enabling lifestyle based sensors and devices. In the market, there's nothing that is a slap-on wearable that uses perspired sweat for diagnostics. And I think we are the closest. If we find the right partner, then within a 12-month window, we hope to license our technology and have our first products in the market."

Explore further: Bioengineers create sweat-based sensor to monitor glucose

More information: Rujuta D. Munje et al, A new paradigm in sweat based wearable diagnostics biosensors using Room Temperature Ionic Liquids (RTILs), Scientific Reports (2017). DOI: 10.1038/s41598-017-02133-0

Google said Friday it would stop scanning the contents of Gmail users' inboxes for ad targeting, moving to end a practice that has fueled privacy concerns since the free email service was launched.

Like driving a car despite a glowing check-engine light, large buildings often chug along without maintenance being performed on the building controls designed to keep them running smoothly.

Microphones, from those in smartphones to hearing aids, are built specifically to hear the human voicehumans can't hear at levels higher than 20 kHz, and microphones max out at around 24 kHz, meaning that microphones only ...

Researchers at The University of Texas at Dallas are getting more out of the sweat they've put into their work on a wearable diagnostic tool that measures three diabetes-related compounds in microscopic amounts of perspiration.

Researchers at the College of Engineering at Carnegie Mellon University have developed a novel design approach for exoskeletons and prosthetic limbs that incorporates direct feedback from the human body. The findings were ...

In a proof-of-concept study, North Carolina State University engineers have designed a flexible thermoelectric energy harvester that has the potential to rival the effectiveness of existing power wearable electronic devices ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Continue reading here:
Bioengineers create more durable, versatile wearable for diabetes ... - Phys.Org

Since her diagnosis of Type 1 diabetes in 2009, Madyi Stangl has felt that the disease has placed a cloud on her life limiting her ability to travel and live life.

But that cloud has lifted, thanks to a special golden retriever named Willy.

Willy is a diabetes assistance dog that was given to Stangl by Can Do Canines, a New Hope, Minn., based non-profit organization that trains dogs to help people who live with diabetes, autism, seizures, hearing loss and mobility issues.

Madyi and Willy graduated in a class of 14 on June 10.

Willy can detect changes in Stangls blood sugar levels by scent. He alerts Madyi to high or low blood sugar levels by touching her with his paw. If she doesnt respond, he will whine or whimper and eventually do whatever he needs to do to get her attention. He is trained to bring glucose tablets or even a cell phone to Stangl.

Recently, Stangl had a scary low of 34 during the night. When she failed to respond to Willys touches, he laid over her body until she woke up. She then checked her blood sugar levels and ate food to bring her levels back up to normal, saving her life.

Can Do Canines has produced nearly 600 teams of dogs and their human companions since opening in 1989, according to Client Services Coordinator Sarah Schaff.

The organization can give away the dogs, which are sold by other organizations for $20,000 or more, because of volunteers and many donors, Schaff says.

Funding comes from donations from individuals, companies and grants. Schaff reports that the organization does not receive any state or federal funds, relying solely on donations, fundraisers and bequests.

Puppies are bred in a cooperative program with other certified service dog organizations, raised by volunteers and many receive their initial training in six Minnesota and two Wisconsin prisons.

Schaff notes that the prison environment is good for the dogs as well as the inmates.

It gives dogs a 24/7 taste of what life will be like when they are working, she says, adding that there are many studies pointing to the therapeutic benefits for the inmate handlers as well.

The organization has a screening process to find suitable candidates to match with dogs that are in the system or are in training.

It takes two years to raise and train a dog to be an assistance animal, Schaff says.

Madyi lives ub Minneapolis and works as the Operations Lead for the University of Minnesota Physicians, and Willy accompanies her to work as well. He even alerted a diabetic co-worker to a low blood sugar level.

Stangl grew up with dogs and reports that having Willy around is like having a big security blanket that I carry with me all the time. She is now more confident as well.

Even though Im going to continue on as this girl with this physical reminder of my disability, Im a little prouder because Im able to shed light on diabetes. Diabetes is an invisible illness, but it is something that needs to be seen because its not something to be taken lightly, she says.

Even though Willy is a beautiful and friendly dog, Stangl asks that people should refrain from touching him or any other assistance dog without permission of the owner.

When we are out in public and Willy is wearing his vest, its important not to make eye contact or distract him, Stangl says. He is working for me, and if he gets distracted, he stops working and that could be dangerous.

Schaff says that Can Do Canines is in need of volunteers to raise and train labrador, collie and poodle puppies for two years and return them to the company for further training.

Here is the original post:
'Lifting the cloud' of diabetes with a special dog | News ... - Burnett County Sentinel (subscription)

Video Gallery - WTXL Video Template

TALLAHASSEE, Fla. (WTXL)- More than 1 million Americans are living with Type 1 diabetes (T1D), an autoimmune disease where the pancreas stops making insulin.

One out of every 400 children has T1D, and for one Tallahassee family, a pair of twins were both diagnosed before the age of 2.

"It can happen to anyone. We don't have it in our families," said Rebeka Joseph, the mother of Eva and Leah Joseph."This was a strike of lightning that hit us. Twice."

Leah was diagnosed when she was just 10 months old. Her parents thought she had the flu, but her blood sugar level was dangerously high.

"My baby was 10 months old, and she had diabetes," Rebekah said. "My life changed forever in that moment."

Just nine months later, Eva was diagnosed with T1D. Rebekah was able to detect it, thanks to the medical team at Tallahassee Memorial.

"As they grow up, there will be physicians here who can continue to take care of them," said Dr. Larry Deeb, a pediatric endocrinologistat TMH. "There will be the Diabetes Center that can continue to offer support at every stage of life."

"We're there to continue training and making sure that they make the transition -- being able to learn some of the care things themselves, so that they can take care of their bodies as they grow and develop," saidKatherine Owen, a certified diabetes educator at TMH.

TMH provided the girls with devices that monitor and administer insulin throughout the day.

"It's an hourly -- almost minute-to-minute disease," Rebekah said.

As the girls grow up, the family wants to make sure their teachers know how to handle issue with diabetes. TMH trained the staff at Good Samaritan Academy to do just that.

"The girls are able to develop as little people that can play with other kids," Rebekah said. "I want them to realize how normal they are. There's really no difference."

That's what Belinda Rodebaugh hopes for, too. She was diagnosed when she was 5 years old.

"It is part of your life, and it never goes away. However, it will respond to things that you do," Rodebaugh said."So, the more you research what you eat and what you don't is a really good thing."

The twins will celebrate their second birthday in September. The family says the support they've received gives them confidence to manage any challenge that comes their way.

Visit link:
Tallahassee twin toddlers learn to live with Type 1 diabetes - WTXL ABC 27

OLEAN The Street Classics Car Club presented a $5,000 check to JDRF for Type 1 diabetes research Thursday at its weekly cruise night.

Since 1991 the club has donated more than $70,000 to the organization formerly known as the Juvenile Diabetes Research Foundation, said Karen Swierski, executive director of JDRFs Western New York chapter. Swierski was at cruise night in the Olean Center Mall parking lot to accept the check from club President Jim McKelvey and Treasurer John Ricci, as well as other club members.

The club began donating to support the organizations mission of finding a cure for Type 1 diabetes because one of its founding members had the disease.

We keep plugging away, McKelvey said.

About 1.25 million Americans have Type 1 diabetes, according to a 2014 report by the Centers for Disease Control and Prevention. Type 1 diabetes is an autoimmune disease that affects the bodys ability to produce insulin.

We dont call it juvenile anymore because you dont get rid of it as you get older, Swierski said.

Donations to JDRF go toward both research and outreach.

Our mission is to find a cure for Type 1 diabetes, thats our main focus, but we realize theyre are a lot of people with Type 1 out there and we have to help them manage their disease, Swierski said.

Many donations come from groups like the Street Classics Car Club.

We do some big fundraisers, we do work with the federal government, but it's the community fundraisers like this group that really make a difference, Swierski said.

As of 2016, the clubs 25th anniversary, the club has donated more $84,000 to a variety of local charities, according to club officials. Organizations who have benefited include the SPCA in Cattaraugus County, Olean Food Pantry and St. Bonaventure University's Warming House. Individuals, who needed assistance after fires or needed ramps to get into their homes, have also been helped.

We try to help everybody, but a lot of it just depends on our cruise nights and our Car Show and our sponsors, McKelvey said.

The clubs 26th annual Street Classics Car Show will take place Aug. 6 at Firemans Park in Allegany. There will be 50/50 drawings, a Chinese auction, food, games and live music. The event runs from 9 a.m. to 4 p.m. The cruise nights, held every Thursday, will last through Labor Day.

(Contact reporter Tom Dinki at tdinki@oleantimesherald.com. Follow him on Twitter, @tomdinki)

View post:
Street Classics Car Club makes annual donation for Type 1 diabetes research - Olean Times Herald

American Diabetes Association officials are offering a summer diabetes-prevention camp in Santa Clarita from July 1516, 2017, from 9 a.m. to 4 p.m. at the Boys & Girls Club of Santa Clarita.

This camp is available for 7- to 15-year-olds who are at risk for diabetes or that have a family history of Type 2 diabetes.

To register, visit the Camp Power Up website at http://www.diabetes.org/camppowerupsantaclarita or call 323-966-2890.

Obesity continues to pose a threat to the health of Americans, as Type 2 diabetics make up 90-95 percent of all diabetics in the world.

Approximately 208,000 Americans under age 20 are estimated to have diagnosed diabetes, according to the American Diabetes Association.

In order to combat this statistic, create new habits and become knowledgeable about Type 2 diabetes prevention, the diabetes camp will focus on exercise, proper nutrition and fellowship between children in similar health circumstances.

Parents and other family members are encouraged to attend camp on Sunday in order to reinforce the healthy lifestyle their children learned about on Saturday.

In addition to the weekend long camp experience, all children and their families are invited to attend three Reunion Events hosted at the Boys & Girls Club in Newhall.

Risk factors for Type 2 diabetes are being overweight, sedentary, and having a family history of diabetes. African Americans, Hispanics/Latinos, Native Americans, Asian Americans and Pacific Islanders are at an increased risk for developing the disease.

However, Type 2 diabetes can be reversed via exercise, nutrition, and a change in lifestyle choices.

About the American Diabetes Association

The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (800-342-2383) or the Los Angeles office at 323.966.2890 or visit http://www.diabetes.org Find the Los Angeles office on Facebook (adalosangeles), Twitter (@ada_losangeles) and Instagram (@adalosangeles).

See the rest here:
Diabetes-Prevention Camp To Be Held In Santa Clarita ... - KHTS Radio

Dr. Ralph Defronzo talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about SGLT-2, GLP-1, and the drugs he recommends despite standard practice.

Dr. Ralph Defronzo, MD is Professor of Medicine and Chief of the Diabetes Division at the University of Texas Health Diabetes Center in San Antonia, Texas. Dr. Defronzo is also Deputy Director of the Texas Diabetes Institute.

Transcript of this video segment:

Steve Freed:You were one of the first to use triple therapy. Certainly a more aggressive attitude. Now we have drugs that actually prevent or reduce your risk for death. Now were coming out, were finding out the SGLT-2s may cause amputation of your toes. It may cause other issues. I dont think theres a drug on the planet that doesnt have side effects. But were not going to die from the loss of a toe. What are your thoughts even when it comes to SGLT-2s? I know theyre fairly expensive right now. Competition hopefully will reduce that. What are your thoughts about the SGLT-2 drugs and the GLP-1s?

Dr. Defronzo:Let me just back up before I talk about this amputation issue, because its going to be very controversial. To me, Ive always been a strong believer that you need to understand what causes type 2 diabetes. NIH spends millions and millions of dollars to help us try to define what causes the disease. If you know what causes the disease, you ought to use medications to reverse the problem. Sulfonylureas clearly dont do that. In my opinion, these drugs, other than cost, really should not be being used in our diabetic patients. We have much better armor material. So if I had to list the drugs, and this may be a little bit different from what other people tell you. I would put a tie between GLP-1 receptor agonist and pioglitazone. And very close to those two, I would put SGLT-2 inhibitor. Id put Metformin as a good drug but lower down. Those are my four good drugs. Then way down, Id put DPP-4 inhibitors and I just dont use sulfonylurea drugs. I dont believe that theres any need for these drugs. Youd have to be very hard pressed that people could not afford any other drug before Im going to resort to using sulfonylurea drugs. Weve done a very large study with triple therapy. Its now into its 5th year. We use a combination of pioglitazone, a GLP-1 receptor agonist, and Metformin. Because when we started these studies, SGLT-2 inhibitors were not around. I can tell you now, the results are phenomenal. These people have three years later normal beta-cell function. They have a 60% improvement in insulin sensitivity. They lose weight. Theres minimal hypoglycemia. We just published a very large study inDiabetes Care, its called the Qatar Study, where theyre going to play the World Cup. We took people who had failed completely on Metformin and sulfonylurea. Their A1C was 10.1. They had ten and a half duration of this disease. We added a GLP-1 receptor agonist plus pioglitazone. A year and a half later, they have an A1C of 6. So, the beta cells, Id rather say, theyre not dead, theyre hibernating. People dont recognize that the TZDs have a huge effect on the beta cell. GLP-1 receptor agonists have a huge effect on the beta cell. And then pioglitazone also has a good insulin sensitizing effect. If I had to do this study over again, I actually would replace the Metformin with the SGLT-2 inhibitor. But these are all good drugs and docs need to learn how to mix and match them. Then they also need to remember that even though you start on two or three drugs, or even you start on one drug, you need to follow the patient to see what happens. If you get a gratifying response, great. But if you dont, then you need to move on quickly, either adding one or two additional drugs.

Steve Freed:Now, you had mentioned, if you go back 50 years, we had one oral drug. Today, we have a couple million possible combinations if you include insulin in there. What you see coming down the pike as far as the future because it used to be simple. You go to your doctor, and he gives you a prescription for sulfonylurea. Today, theres so many options and so many new drugs that each of them has side effects. Theyre all a little bit different. Theyre certainly better than what we had. How do you teach a physician, what possible combination he should use? Is it just trial-and-error?

Dr. Defronzo:Well, I think for endocrinologists, its a little bit easier because this is our job. I think the real problem is amongst primary care physicians because they have to learn all of these new diabetes drugs. Then they have G.I. problems. They have to learn all of these new G.I. drugs. Then they have people presenting with arthritis and collagen vascular disease. Then we have this whole new plethora of immuno-suppressive drugs. I feel sorry in a certain way for the primary care physician because hes supposed to be an expert in everything. Well, thats not possible. The good part is we have very good medications. So thats an advantage. Sometimes I see patients coming to me, I wonder why are they on these drugs when theyre not well controlled, when there are better drugs. It sounds easy for us. I see a patient literally in 10 to 15 minutes, I can handle all the problems. I know instantaneously what to do with glucose, lipids, blood pressure, and cardiovascular issues. Thats basically the major part of diabetes cardiovascular hypertension treatment. And since Im board certified in nephrology as well, I know if they get kidney problems what to do. So for me its very easy to take care of diabetic patients. Its not so easy for primary care physicians and then on top of all of that, we have cost. These newer drugs are really quite expensive. Also, if you prescribe a drug thats not on the patients formulary and he goes to pick it up and its $500, believe me you havent prescribed any drug, because hes not going to get it. Even though, the docs may understand what drugs do and what are the good ones, not always can you prescribe them for your patients.

Return to main page.

Read the rest here:
Dr. Ralph Defronzo Part 3, Diabetes Medications - Diabetes In Control

LOOMIS Becton Dickinson wants to help cure or find a better way to treat diabetes, so the medical equipment manufacturer supports the Juvenile Diabetes Research Foundation.

To do so, BD is sponsoring a 2K Color Fun Run July 1 in Loomis. It will begin at Loomis High School and will end at the communitys water park.

Usually, we sponsor an event inside the plant, but we decided to do something different this year, said Holdrege BD employee and event leader Sheri Freeland.

Donations will benefit the Juvenile Diabetes Research Foundation Lincoln and Greater Nebraska Chapter to create a world without type 1 diabetes, an autoimmune disease in which a persons pancreas stops producing insulin. Insulin is a hormone people need to get energy from food.

The disease can suddenly strike both children and adults. Type 1 diabetes is unrelated to diet or lifestyle. People with type 1 diabetes must regularly monitor their blood-sugar levels, inject or continually infuse insulin through a pump, and carefully regulate insulin doses with eating and activity 24 hours a day.

The juvenile diabetes foundation funds research to deliver new treatments and therapies that make day-to-day life with diabetes easier, safer and healthier until it can prevent and one day cure the disease.

After hearing a speech from 13-year-old Riley Kinnan, who was diagnosed with diabetes at the age of 7, Freeland knew leading this event was something she wanted to do.

(Her speech) was interesting and motivating. Since Ive worked (at BD) for 36 years, I felt like I should do something, and I knew this was a great way to help out, said Freeland.

Riley, an eighth-grader to be from Lincoln, is an ambassador for the juvenile diabetes foundation. She is very passionate about helping younger children, especially those who are also dealing with the challenges of a diabetes diagnosis.

In the past, BD has sponsored diabetes foundation events such as chili cookoffs, salsa-making contests, hamburger feeds and silent auctions. It has sponsored the juvenile diabetes foundation for six or seven years.

There are 30 people signed up for the Color Run, and Freeland said she has already sold 80 T-shirts for the occasion. All proceeds are going to the juvenile diabetes foundation, and BD is matching the money raised.

Freeland said she is grateful for the number of people who have signed up so far to participate.

We werent sure if we would have enough people or money to put this event together, but we ended up having many volunteers and people in the community willing to help out.

With continued publicity for the event, Freeland hopes to help those suffering with diabetes.

Its a scary disease, and it can affect so young. There are kids that are 2 or even younger that have it, and its terrifying to think about how many shots to have daily and watching what you eat constantly. Its not like you can take a pill and make it go away. For kids, it just sucks, Freeland said.

Go here to read the rest:
BD fun run to benefit juvenile diabetes research - Kearney Hub

According to the latest report published by Credence Research, Inc.Diabetes Devices Market Growth, Future Prospects and Competitive Analysis, 2016-2022,the global diabetes devices market was valued at USD 20.4 Bn in 2015, and is expected to reach USD 28.2 Bn by 2022, expanding at a CAGR of 4.6% from 2016 to 2022.

Browse the fullreport Diabetes Devices: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/diabetes-devices-market

Market Insights

With approximately 385 Mn diabetic patients and a burden of 175 Mn undiagnosed population, the burden of diabetes is significant. Lifestyle, increase in obesity prevalence, dietary changes and ageing are some of the critical factors contributing to the growing prevalence of diabetes worldwide. The global diabetes management market is majorly driven by rising disease prevalence, technological innovation, growing preference for automated disease management solutions are the prime drivers of diabetes devices market.

Growth of the global diabetes management devices market is also supported by significant investments, scope of penetration in middle- and low-income countries and increasing awareness in patient population about effective diabetes management and thereby prevention of disease related complications. On the other hand, high costs of novel diabetes management products and monitors, compliance issues, safety concerns and reimbursement issues are some of the market hindrances faced by the diabetes device manufacturers.

This report classifies the overall diabetes devices market into insulin delivery devices and glucose monitoring devices segments. The insulin delivery devices segment studies individual market for insulin pumps, insulin syringes, insulin pens and insulin inhalers. The glucose monitoring products studied in this report include test strips, lancing devices and lancets, glucose meters and continuous glucose monitors. Insulin delivery devices currently take the larger share of the overall diabetes devices market and it is anticipated that the demand for these products shall remain high through the forecast period. Additionally, continuous glucose monitors is anticipated to be the fastest growing segment in the total market, where the growth is facilitated by rapid technological innovation in this field by players such as Dexcom and prove efficiency of these devices in management of both type 1 and type 2 diabetes.

Geographically, North America and Europe are the largest regional markets for diabetes devices. High awareness, diabetes prevalence and evolved reimburse systems for novel drug delivery and monitoring systems are the prime market growth drivers in these regions. Furthermore, Asia-Pacific and Middle East and Africa are the fastest growing regions in the global market. Phenomenal rise in diabetes prevalence in countries such as India, China and Middle East countries are the major growth facilitators in these region.

The overall diabetes devices market is led by F. Hoffmann La Roche through its flagship product line Accu Chek and is followed by Animas Corporation and LifeScan with their wide product offering. Eli Lilly currently is among the top players in the diabetes delivery devices segment.

Download Sample:http://www.credenceresearch.com/sample-request/57947

Other Best Selling Reports:http://healthwant.com/2017/03/01/global-drug-delivery-technologies-market-is-predicted-to-hit-284-71-bn-by-2023/

Original post:
Diabetes Devices Market Is Predicted To Hit USD 28.2 Bn By 2022, Credence Research - Technorati